MGTX Insider Trading
Insider Ownership Percentage: 8.40%
Insider Buying (Last 12 Months): $5,000,000.00
Insider Selling (Last 12 Months): $382,838.33
MeiraGTx Share Price & Price History
Current Price: $6.78
Price Change: ▼ Price Decrease of -0.55 (-7.50%)
As of 03/31/2025 05:00 PM ET
MeiraGTx Insider Trading History
MeiraGTx Institutional Trading History
Data available starting January 2016
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.
Read More on MeiraGTx
Volume
1,030,813 shs
Average Volume
286,946 shs
Market Capitalization
$534.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.23
Who are the company insiders with the largest holdings of MeiraGTx?
Who are the major institutional investors of MeiraGTx?
Which major investors are selling MeiraGTx stock?
During the last quarter, MGTX stock was sold by these institutional investors:
- Prosight Management LP
- Adage Capital Partners GP L.L.C.
- Royce & Associates LP
- 683 Capital Management LLC
- Russell Investments Group Ltd.
- Dimensional Fund Advisors LP
- Los Angeles Capital Management LLC
- Millennium Management LLC
During the previous year, company insiders that have sold MeiraGTx company stock include:
- Perceptive Advisors Llc (Director)
- Alexandria Forbes (CEO)
Learn More investors selling MeiraGTx stock.
Which major investors are buying MeiraGTx stock?
In the previous quarter, MGTX stock was purchased by institutional investors including:
- Sanofi
- Woodline Partners LP
- Long Focus Capital Management LLC
- Knott David M Jr
- Geode Capital Management LLC
- Janney Montgomery Scott LLC
- Nuveen Asset Management LLC
- Northern Trust Corp